| |
| |
|
| Insider
Information: |
Geary Richard S |
| Relationship: |
Officer Level 14 |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
87,938 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,599,302 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
87,938 |
|
|
| Total
Value |
$3,599,302 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -34.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Officer Level 14 |
2024-02-29 |
87,938 |
2009-01-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Officer Level 14 |
• – – |
2024-02-29 |
4 |
A |
$34.43 |
$20,793 |
D/D |
604 |
87,938 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2024-02-02 |
4 |
S |
$50.04 |
$98,135 |
D/D |
(1,961) |
87,334 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,820 |
89,295 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2024-01-17 |
4 |
S |
$50.42 |
$369,960 |
D/D |
(7,338) |
85,475 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2024-01-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,852 |
92,813 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2023-12-21 |
4 |
S |
$49.29 |
$202,681 |
D/D |
(4,112) |
72,961 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2023-12-21 |
4 |
OE |
$47.34 |
$194,662 |
D/D |
4,112 |
77,073 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2023-12-20 |
4 |
OE |
$47.34 |
$307,710 |
D/D |
6,500 |
79,461 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2023-12-20 |
4 |
S |
$49.64 |
$322,643 |
D/D |
(6,500) |
72,961 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2023-12-14 |
4 |
S |
$49.21 |
$526,236 |
D/D |
(10,613) |
72,961 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2023-12-14 |
4 |
OE |
$47.34 |
$502,419 |
D/D |
10,613 |
77,003 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Officer Level 14 |
• – – |
2023-08-31 |
4 |
A |
$30.56 |
$31 |
D/D |
1 |
72,961 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2023-02-28 |
4 |
A |
$30.52 |
$17,546 |
D/D |
575 |
72,960 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2023-02-06 |
4 |
S |
$40.66 |
$78,070 |
D/D |
(1,920) |
72,385 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2023-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,822 |
74,305 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2023-01-18 |
4 |
S |
$39.57 |
$311,525 |
D/D |
(7,873) |
70,483 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2023-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,983 |
78,356 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2022-02-28 |
4 |
A |
$28.37 |
$17,620 |
D/D |
621 |
56,373 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2022-01-18 |
4 |
D |
$30.12 |
$229,063 |
D/D |
(7,605) |
55,752 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Officer |
• – – |
2022-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,391 |
63,357 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Offc |
• – – |
2021-08-31 |
4 |
A |
$33.80 |
$1,555 |
D/D |
46 |
41,966 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Offc |
• – – |
2021-02-26 |
4 |
A |
$44.54 |
$18,440 |
D/D |
414 |
41,920 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Offc |
• – – |
2021-01-15 |
4 |
D |
$61.28 |
$392,069 |
D/D |
(6,398) |
41,506 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Offc |
• – – |
2021-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,598 |
47,904 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Development Offc |
• – – |
2021-01-13 |
4 |
AS |
$59.50 |
$8,390 |
D/D |
(141) |
30,306 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
